Medscape InDiscussion: Psoriasis16 Jul 2025

Creams, Foams, and New Formulations: Rethinking Topical Therapy for Psoriasis

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep6-2026a100069z. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

expertscape https://expertscape.com/

PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact https://pubmed.ncbi.nlm.nih.gov/40465498/

Topical Corticosteroids https://www.ncbi.nlm.nih.gov/books/NBK532940/

Psoriasis Clinical Guideline https://www.aad.org/member/clinical-quality/guidelines/psoriasis

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/

Keratosis Pilaris https://emedicine.medscape.com/article/1070651-overview

Review of the Mechanism of Action of Coal Tar in Psoriasis https://pubmed.ncbi.nlm.nih.gov/28814117/

Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence https://pubmed.ncbi.nlm.nih.gov/28188596/

Polyaphron Dispersion Technology, a Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application https://pubmed.ncbi.nlm.nih.gov/36050567/

Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits https://pubmed.ncbi.nlm.nih.gov/34106439/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(23)

Can AI Cut Your Psoriasis Admin Hours in Half?

Dr Faranak Kamangar joins Dr Steven Feldman to discuss how AI tools are cutting psoriasis admin hours, improving diagnostic accuracy, and freeing clinicians for more patient-facing care. Relevant disc...

25 Jun 20min

How Confident Should We Be in Psoriasis Biosimilars?

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars. Relevant disclosures can be found with the episode show notes on Medsca...

27 Mai 20min

How Much Monitoring Is Enough in Psoriasis Care?

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice. Relevant disclosures can be found with the ep...

23 Apr 22min

Next-Gen Oral Therapies Reshaping Psoriasis Care

Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care. Relevant disclosures can be found with the episo...

25 Mar 20min

Can Fixing Adherence Fix Psoriasis Outcomes?

Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis. Relevant disclosures can be found with th...

25 Mar 26min

Smartphones and the Future of Psoriasis Care

Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps. Relevant disclosure...

17 Jun 202521min

What's New in Psoriasis? Dermasphere Podcasters Weigh In

Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast Dermasphere, to discuss trends and hot topics in psoriasis. Relevant disclosures can be found with the episode show ...

15 Mai 202523min